TherapeuticsMD (TXMD) Dividends payables (2010 - 2012)

TherapeuticsMD's (TXMD) quarterly Dividends payables came in at $41359.0 in Q4 2012, little changed on a QoQ basis from $41359.0 in Q3 2011.

TherapeuticsMD (TXMD) Dividends payables (2010 - 2012) Analysis & Trends

TherapeuticsMD (TXMD) has 3 years of Dividends payables data on file, last reported at $41359.0 in Q4 2012.

Quarterly Dividends payables changed N/A year-over-year to $41359.0 in Q4 2012, while the trailing twelve-month figure through Dec 2012 was $41359.0 (changed N/A YoY) and the FY2012 annual result came in at $41359.0, changed N/A from the prior year.
Dividends payables was little changed at $41359.0 in Q4 2012, from $41359.0 in the prior quarter.
In the past five years, Dividends payables ranged from a high of $41359.0 in Q4 2010 to a low of $41359.0 in Q4 2010.
A 3-year average of $41359.0 and a median of $41359.0 in 2010 frame the typical range for Dividends payables.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Dividends payables (Qtr)
1	Haleon	44.51 Bn	43.55 Bn	-	-
2	Teva Pharmaceutical Industries	43.52 Bn	39.86 Bn	2.15 Bn	-
3	Zoetis	32.43 Bn	30.75 Bn	1.05 Bn	221.00 Mn
4	Takeda Pharmaceutical	28.63 Bn	22.83 Bn	5.10 Bn	-
5	United Therapeutics	21.87 Bn	19.21 Bn	683.80 Mn	-
6	Viatris	18.98 Bn	18.09 Bn	1.46 Bn	-
7	Neurocrine Biosciences	15.43 Bn	15.04 Bn	935.80 Mn	-
8	Elanco Animal Health	12.02 Bn	11.49 Bn	798.00 Mn	-
9	Dr Reddys Laboratories	10.14 Bn	9.98 Bn	-	-
10	TherapeuticsMD	23.78 Mn	14.60 Mn	-	-

Download Data